edetic acid has been researched along with Infarction, Middle Cerebral Artery in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Chao, LC; Huang, CC; Huang, SY; Lee, AH; Lee, EJ; Lin, YW; Shan, YS; Tai, SH; Wu, TS | 1 |
Kim, TY; Kim, YH; Kim, YJ; Koh, JY; Lee, JY | 1 |
Hara, H; Hasegawa, T; Iwama, T; Kotani, Y; Nagase, H; Nakajima, Y; Satoh, M; Shimazawa, M; Yoshimura, S | 1 |
3 other study(ies) available for edetic acid and Infarction, Middle Cerebral Artery
Article | Year |
---|---|
Lithium upregulates growth-associated protein-43 (GAP-43) and postsynaptic density-95 (PSD-95) in cultured neurons exposed to oxygen-glucose deprivation and improves electrophysiological outcomes in rats subjected to transient focal cerebral ischemia foll
Topics: Animals; Brain Ischemia; Brain-Derived Neurotrophic Factor; Disks Large Homolog 4 Protein; Edetic Acid; GAP-43 Protein; Glucose; Glycogen Synthase Kinase 3 beta; Infarction, Middle Cerebral Artery; Lithium; Lithium Chloride; Male; N-Methylaspartate; Neurons; Neuroprotective Agents; Oxygen; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Sodium Dodecyl Sulfate | 2022 |
Essential role for zinc-triggered p75NTR activation in preconditioning neuroprotection.
Topics: Animals; Apoptosis; Calcium; Cell Culture Techniques; Cerebral Cortex; Cerebral Infarction; Chelating Agents; Disease Models, Animal; Edetic Acid; Embryo, Mammalian; Enzyme Activation; Excitatory Amino Acid Agonists; Infarction, Middle Cerebral Artery; Ischemic Preconditioning; Laser-Doppler Flowmetry; Male; Mice; Mice, Transgenic; N-Methylaspartate; Neurons; Poly(ADP-ribose) Polymerases; Rats; Rats, Sprague-Dawley; Receptor, Nerve Growth Factor; Time Factors; Zinc | 2008 |
Propofol exerts greater neuroprotection with disodium edetate than without it.
Topics: Anesthetics, Intravenous; Animals; Apoptosis; Benzimidazoles; Brain Ischemia; Cell Count; Cell Survival; Chelating Agents; Drug Synergism; Edetic Acid; Fluorescent Dyes; Glucose; Hypoxia; In Situ Nick-End Labeling; Infarction, Middle Cerebral Artery; Male; Mice; Neuroprotective Agents; Neurotoxicity Syndromes; PC12 Cells; Propofol; Rats; Zinc | 2008 |